Delivering innovative health with generative AI solutions at Merck
This is a YouTube video page; WebFetch could only retrieve the video's title tag and YouTube's boilerplate navigation/footer content, not the actual video description or transcript. Based on the title alone, the video covers Merck's use of generative AI solutions with AWS, but no specific detail about the "50% false reject reduction across production lines" claim from the old description could be confirmed from the fetched page content.
AWS is Amazon's cloud platform, used across pharma for genomics compute, SageMaker/Bedrock model training, and healthcare-and-life-sciences-specific services like Amazon HealthOmics.
This sits in the Build stage of the AI use-case lifecycle: Named examples from the foundation-model labs and platforms pharma teams use to actually construct, train and generate the model or application.
Published by AWS on its own site — read the original case study on youtube.com ↗
Note: JS-rendered video page; only title metadata was extractable, no description or transcript content available via WebFetch.
Related use cases
- 01Sanofi Accelerates Drug Discovery with AI on AWS
- 02Key Takeaways from Gilead's Innovation Talk at re:Invent 2023
- 03AWS Life Sciences Symposium 2025 | Development Assistants at AstraZeneca
- 04Cloud-based genomics-sequencing data processing at scale
- 05Roche Accelerates Personalized Healthcare R&D While Reducing Costs Using AWS HealthOmics
- 06AWS re:Invent 2023 - Customer Keynote Pfizer